Detalhe da pesquisa
1.
Impaired diaphragmatic motility in treatment-naive adult patients with spinal muscular atrophy improved during nusinersen treatment.
Muscle Nerve
; 68(3): 278-285, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37466180
2.
Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
BMC Neurol
; 23(1): 216, 2023 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37280513
3.
Treatment expectations and perception of therapy in adult patients with spinal muscular atrophy receiving nusinersen.
Eur J Neurol
; 28(8): 2582-2595, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33960080
4.
Correction: Cognitive performance of adult patients with SMA before and after treatment initiation with nusinersen.
BMC Neurol
; 23(1): 241, 2023 Jun 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37349715
5.
'Reading the palm' - A pilot study of grip and finger flexion strength as an outcome measure in 5q spinal muscular atrophy.
Brain Dev
; 46(5): 189-198, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331667
6.
Macrophage inclusions in cerebrospinal fluid following treatment initiation with antisense oligonucleotide therapies in motor neuron diseases.
Neurol Res Pract
; 6(1): 11, 2024 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38383503
7.
Troponin T is elevated in a relevant proportion of patients with 5q-associated spinal muscular atrophy.
Sci Rep
; 14(1): 6634, 2024 03 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38503830
8.
Long-term efficacy and safety of nusinersen in adults with 5q spinal muscular atrophy: a prospective European multinational observational study.
Lancet Reg Health Eur
; 39: 100862, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38361750
9.
Affection of Respiratory Muscles in ALS and SMA.
J Clin Med
; 11(5)2022 Feb 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-35268254
10.
Prevalence of Anti-Adeno-Associated Virus Serotype 9 Antibodies in Adult Patients with Spinal Muscular Atrophy.
Hum Gene Ther
; 33(17-18): 968-976, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35943879
11.
Glial fibrillary acidic protein in cerebrospinal fluid of patients with spinal muscular atrophy.
Ann Clin Transl Neurol
; 9(9): 1437-1448, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35951535
12.
Validity and reliability of the German multidimensional fatigue inventory in spinal muscular atrophy.
Ann Clin Transl Neurol
; 9(3): 351-362, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35191616
13.
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy.
Orphanet J Rare Dis
; 16(1): 330, 2021 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34321067
14.
Treatment satisfaction in 5q-spinal muscular atrophy under nusinersen therapy.
Ther Adv Neurol Disord
; 14: 1756286421998902, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33747131
15.
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment.
Ann Clin Transl Neurol
; 8(5): 1049-1063, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33792208